Intrinsiqs

Is Bruker Corporation overvalued?

Bruker Corporation (BRKR) looks fairly valued — trading about 10% below its fair value.

Fairly valued
Current price $61.59 Fair value $67.67
Price
$61.59
Fair value
$67.67
Current P/E
33.8
Normal P/E
37.2
Market cap
$9.41B
Dividend yield
0.3%
Return on equity
-5.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BRKR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.